The impact of psoriatic arthritis on quality of life: a systematic review

The impact of psoriatic arthritis on quality of life: a systematic review

<p><strong>Background:</strong> Psoriatic arthritis (PsA) is a chronic inflammatory condition that can affect individuals of all ages. Patients may experience a range of physical and psychological issues.</p> <br> <p><strong>Objective:</strong> To exam...

Descripció completa

Dades bibliogràfiques
Autors principals:	James, L, Hailey, L, Suribhatia, R, McGagh, D, Amarnani, R, Bundy, C, Kirtley, S, O'Sullivan, D, Steinkoenig, I, White, J, Vivekanantham, A, Coates, LC
Format:	Journal article
Idioma:	English
Publicat:	SAGE Publications 2024

Ítems similars

Lifestyle modifications and nonpharmacological interventions to improve outcomes in psoriatic arthritis. A systematic review
per: Hailey, LH, et al.
Publicat: (2023)

The impact of psoriatic arthritis on quality of life: a systematic review
per: Lija James, et al.
Publicat: (2024-12-01)

Developing evidence-based patient focused learning materials to support health behaviour change for people living with psoriatic arthritis
per: Hailey, LH, et al.
Publicat: (2023)

Current treatments and recommendations
per: Vivekanantham, A, et al.
Publicat: (2021)

Developing evidence-based patient-focused learning materials to support health behaviour change for people living with psoriatic arthritis
per: Shona Kirtley, et al.
Publicat: (2023-07-01)

Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
per: McGagh, D, et al.
Publicat: (2020)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
per: Vivekanantham, A, et al.
Publicat: (2024)

Identification of psoriatic arthritis in patients with psoriasis
per: Coates, LC, et al.
Publicat: (2023)

Actigraphy-derived physical activity levels and circadian rhythm parameters in patients with psoriatic arthritis: relationship with disease activity, mood, age and BMI
per: Dylan McGagh, et al.
Publicat: (2023-07-01)

Psoriatic arthritis: prospects for the future
per: Hackett, S, et al.
Publicat: (2022)

Measuring outcomes in psoriatic arthritis
per: Ogdie, A, et al.
Publicat: (2020)

The road to personalised medicine in psoriatic arthritis
per: White, JPE, et al.
Publicat: (2021)

Outcome measures in psoriatic arthritis: where next?
per: Hackett, S, et al.
Publicat: (2022)

How should we define disease and outcomes in axial psoriatic arthritis?
per: Coates, LC
Publicat: (2021)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
per: Soriano, ER, et al.
Publicat: (2023)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
per: Coates, LC, et al.
Publicat: (2022)

The role of ultrasound in psoriatic arthritis — do we need a score?
per: D'Agostino, MA, et al.
Publicat: (2019)

Clinical, genetic and omics-based biomarkers that might support the identification of the development of psoriatic arthritis in individuals with psoriasis – a narrative review of the literature
per: Grohmann, T, et al.
Publicat: (2024)

Psoriatic arthritis
per: FitzGerald, O, et al.
Publicat: (2021)

The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership
per: Hailey, L, et al.
Publicat: (2022)

Psoriatic arthritis in developing and resource-poor countries
per: Maharaj, AB, et al.
Publicat: (2020)

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate
per: Coates, LC, et al.
Publicat: (2023)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
per: Braun, J, et al.
Publicat: (2023)

Psoriatic Arthritis Priority Setting Partnership: patient and clinician informed considerations for future UK health service delivery
per: James, L, et al.
Publicat: (2024)

Methotrexate in psoriasis and psoriatic arthritis
per: Coates, L, et al.
Publicat: (2020)

Considerations for the definition of remission criteria in psoriatic arthritis
per: Mease, P, et al.
Publicat: (2017)

The need for clarity on the use of glucocorticoids for people with psoriatic arthritis: a call for consensus
per: Tillett, W, et al.
Publicat: (2022)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
per: Ogdie, A, et al.
Publicat: (2023)

Clinical, genetic and omics-based biomarkers that might support the identification of the development of psoriatic arthritis in individuals with psoriasis: a narrative review of the literature
per: Oliver FitzGerald, et al.
Publicat: (2024-12-01)

Current concepts and unmet needs in psoriatic arthritis
per: Mahmood, F, et al.
Publicat: (2017)

Psoriatic arthritis: prospects for the future
per: Simon Hackett, et al.
Publicat: (2022-03-01)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
per: Coates, L, et al.
Publicat: (2016)

Psoriatic arthritis: An up to date overview
per: Simon Hackett, et al.
Publicat: (2020-01-01)

Classification and outcome measures for psoriatic arthritis
per: Leung, Y, et al.
Publicat: (2018)

Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire
per: Coates, LC, et al.
Publicat: (2020)

A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: a call to action
per: Gratacós, J, et al.
Publicat: (2021)

The State of the Art - Psoriatic Arthritis outcome assessment in clinical trials and daily practice
per: Day, J, et al.
Publicat: (2022)

Personalized medicine - a new reality in psoriatic arthritis?
per: Al-Mossawi, H, et al.
Publicat: (2018)

Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis
per: FitzGerald, O, et al.
Publicat: (2023)

What should be the primary target of "treat to target" in psoriatic arthritis?
per: Coates, LC, et al.
Publicat: (2018)